Richard Barry, President and CEO of Filana Therapeutics, Inc., filed a Form 4 on November 20, 2026, disclosing an open market purchase of common stock on November 18, 2026.
Key Highlights
- Reporting person: Richard Barry, serving as both Director and President & CEO of Filana Therapeutics, Inc.
- Transaction: Purchase (transaction code P) of 44,851 shares of common stock on November 18, 2026.
- Weighted average price: $0.52 per share, with individual transactions ranging from $0.48 to $0.55 per share.
- Beneficial ownership following the transaction: 1,955,947 shares, held indirectly by trust.
- Ownership form: Indirect, held by trust.
- Exchange and ticker: NASDAQ:FLNA
Richard Barry's Open Market Purchase of Filana Therapeutics Common Stock
According to the filing, Richard Barry, who serves as President, CEO, and Director of Filana Therapeutics, Inc. (NASDAQ:FLNA), acquired 44,851 shares of the company's common stock on November 18, 2026, through open market purchases. The filing reports a weighted average purchase price of $0.52 per share. The shares are held indirectly through a trust.
The filing discloses that the purchase was executed across multiple open market transactions at prices ranging from $0.48 to $0.55 per share. Per a footnote in the filing, Barry "undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote." Following the reported transaction, Barry's total indirect beneficial ownership stands at 1,955,947 shares.
The Form 4 was signed by Eric J. Schoen by Power of Attorney and filed on November 20, 2026. The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as that checkbox on the form was not checked.
What Was Disclosed
Filana Therapeutics President and CEO Richard Barry disclosed an indirect purchase of 44,851 shares of common stock on November 18, 2026, at a weighted average price of $0.52, with resulting beneficial ownership of 1,955,947 shares held by trust.




Please wait processing your request...